Oleoylethanolamide
Suppliers
Names
[ CAS No. ]:
111-58-0
[ Name ]:
Oleoylethanolamide
[Synonym ]:
Oleic acid ethanolamide
9-Octadecenamide, N-(2-hydroxyethyl)-, (9Z)-
MFCD08059579
N-(2-Hydroxyethyl)oleamide
N-(Hydroxyethyl)oleamide N-(cis-9-Octadecenoyl)ethanolamine OEA oleoylethanolamide
N-(9Z-octadecenoyl)-ethanolamine
Oleoyl monoethanolamide
(9Z)-N-(2-hydroxyethyl)octadec-9-enamide
N-oleoyl ethanolamide
Oleoylethanolamide
N-Oleoylethanolamine
9-Octadecenamide, N-(2-hydroxyethyl)-, (Z)-
N-Oleoyl-2-aminoethanol
(9Z)-N-(2-Hydroxyethyl)-9-octadecenamide
N-(cis-9-Octadecenoyl)ethanolamine
N-oleoyl ethanolamine
Oleic acid monoethanolamide
EINECS 203-884-8
9Z-octadecenoylethanolamide
Oleoyl Ethanolamide
Chemical & Physical Properties
[ Density]:
0.9±0.1 g/cm3
[ Boiling Point ]:
496.4±38.0 °C at 760 mmHg
[ Melting Point ]:
50-60ºC
[ Molecular Formula ]:
C20H39NO2
[ Molecular Weight ]:
325.529
[ Flash Point ]:
254.0±26.8 °C
[ Exact Mass ]:
325.298065
[ PSA ]:
49.33000
[ LogP ]:
6.36
[ Vapour Pressure ]:
0.0±2.9 mmHg at 25°C
[ Index of Refraction ]:
1.474
[ Storage condition ]:
−20°C
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
2
Articles
Neurobiol. Dis. 74 , 295-304, (2015)
Long-term administration of l-3,4-dihydroxyphenylalanine (levodopa), the mainstay treatment for Parkinson's disease (PD), is accompanied by fluctuations in its duration of action and motor complicatio...
PLoS ONE 6(2) , e16957, (2011)
Continuing improvements in analytical technology along with an increased interest in performing comprehensive, quantitative metabolic profiling, is leading to increased interest pressures within the m...
Anal. Bioanal. Chem 407(6) , 1781-7, (2015)
The endocannabinoid system has been considered as a target for pharmacological intervention. Accordingly, inhibition of fatty acid amide hydrolase (FAAH), a degrading enzyme of the endocannabinoids N-...